Drug dramatically shrinks Prostate Tumors, study finds
- July 23, 2008
There is a general sense in the prostate cancer community that this agent is
extremely promising and is very likely to have an important role in the
management of prostate cancer patients,' said Dr. Howard M. Sandler, a
radiation oncologist at the University of Michigan who is a spokesman for the
American Society of Clinical Oncology.'It's pretty safe to say that we are
going to have a lot more to offer patients when this drug gets approved,' added
Dr. Robert Reiter, a urologist at UCLA's Jonsson Comprehensive Cancer Center
who was not involved in the research.
Radiation helps even when Prostate Cancer
returns ?June 17, 2008
Radiation therapy can
help prolong the lives of men with aggressive prostate cancer whose
tumors return after surgery, U.S.
researchers said on Tuesday.
Radiation therapy given
within two years of recurrence cut the risk of dying from prostate
cancer by two-thirds, compared with those who got no additional
treatment, they said.
Prostate-screening exams may miss cancer in obese
patients, study shows- November 27, 2007
Higher blood volumes probably cause
lower concentrations of prostate-specific antigen, or PSA, in obese prostate
cancer patients, reports a study, leading the authors to speculate screening
with PSA tests might miss some cancers in obese men.
Supports Change to Prostate Cancer Biopsy -
October 2, 2007
an extra step to the standard test for prostate cancer might improve treatment
for some men, a new study finds.
Glaxo's Avodart and Flomax Help Prostate,
Study Says (Update1) - September 4, 2007
Plc's Avodart combined with Boehringer Ingelheim GmbH's Flomax improved
symptoms of enlarged prostate gland better than either drug alone, a study
HIS HEALTH - Diet and prostate cancer -
August 15, 2007
One's diet is believed to play an important
role in the causation of prostate cancer. Epidemiological studies, looking at different
populations where the incidence of prostate cancer varies widely, suggest that
differences in diet may partly account for these variations.
Soy isoflavones may halve prostate
cancer risk - July 25, 2007
intake of soy isoflavones may cut the risk of prostate cancer by 58 per cent,
suggests a new study from Japan.
Changing Your Lifestyle Help Treat Prostate Cancer? -
July 9, 2007
to 73% of men with prostate cancer take nonprescription supplements, and
smaller numbers use diet, exercise, or both in the hope of improving their
outcome. Most of these men also receive conventional therapy, but a few depend
on lifestyle alone. The appeal of lifestyle therapy is obvious but does it